Oral Contraceptives
Progestin and estrogen content of oral contraceptives (birth control pills) chart.
Contraception
Oral Contraceptives Lower Ovarian Cancer Risk in BRCA Carriers
Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers.
Current Use of Hormonal Contraceptives May Up Glaucoma Risk
Women of reproductive age who currently use hormonal contraceptives are at higher risk for developing glaucoma.
Novel Oral Contraceptive Nextstellis Now Available
The approval was based on data from two phase 3 studies that evaluated the safety, acceptability, efficacy, and cycle control of Nextstellis in 3725 women aged 16 to 50.
Risk Factors for Venous Thromboembolism in Adolescent Girls Receiving Hormonal Therapy
Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.
Women With Lifelong Irregular or Long Menstrual Cycles at Higher Risk for T2D
Is the regularity of a woman’s menstrual cycles during her reproductive life a significant and independent predictor for T2D risk?
Lasting Protection Against Ovarian, Endometrial Cancer With OCPs
Increased risk for breast cancer observed, which was seen for up to two years after discontinuation of oral contraceptives
Twirla Transdermal System Now Available for Contraception
Twirla (levonorgestrel and ethinyl estradiol) transdermal system is now available as a method of contraception for use in women of reproductive potential with a BMI <30kg/m2 for whom a combined hormonal contraceptive is appropriate.
FDA Approves Generic Version of Oral Contraceptive Taytulla
Gemmily contains 24 active capsules containing 1mg of norethindrone acetate and 20mcg of ethinyl estradiol and 4 capsules containing 75mg of ferrous fumarate (nonhormonal placebo).
The Art of Managing Long Acting Reversible Contraception for Adolescent Patients
Long-acting reversible contraception, such as hormonal and non-hormonal intrauterine devices (IUDs) and hormonal implants, have been proven safe and effective for adolescent patients.
- Loading...
Loading...
Next post in Androgen and Reproductive Disorders
Loading... 
Loading...